| 产品名称: | HCC2935 |
|---|---|
| 商品货号: | TS209441 |
| Organism: | Homo sapiens, human |
| Tissue: | lung: pleural effusion |
| Cell Type: | epithelial |
| Product Format: | frozen |
| Morphology: | epithelial |
| Culture Properties: | adherent |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease: | adenocarcinoma |
| Age: | 39 years |
| Gender: | male |
| Ethnicity: | Caucasian |
| Storage Conditions: | liquid nitrogen vapor phase |
| Images: | |
| Derivation: | Established from pleural effusion cells of an adenocarcinoma patient who had never smoked. |
| Clinical Data: | 39 years Caucasian male |
| Comments: | This lung adenocarcinoma has an acquired mutation in the EGFR tyrosine kinase domain (E746 - T751 deletion, S752I). |
| Complete Growth Medium: | The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%.
|
| Subculturing: | Volumes used in this protocol are for 75cm2 flask; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes.
Subcultivation Ratio: A subcultivation ratio of 1:4 to 1:6 is recommended Medium Renewal: Every 2 to 3 days |
| Cryopreservation: | Freeze medium: Complete growth medium supplemented with 5% (v/v) DMSO Storage temperature: liquid nitrogen vapor phase |
| Culture Conditions: | Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Temperature: 37°C |
| STR Profile: | Amelogenin: X,Y CSF1PO: 12 D13S317: 12 D16S539: 12 D5S818: 13 D7S820: 12,13 THO1: 7,9 TPOX: 8 vWA: 17 |
| Population Doubling Time: | 105 hours |
| Name of Depositor: | JD Minna, AF Gazdar |
| Deposited As: | Homo sapiens |
| Year of Origin: | May 13, 1999 |